Dr. Khaled Abdel Ghaffar, Minister of Higher Education and Scientific Research, revealed that the pharmaceutical industry occupies a great importance that stems from its close relationship to human health and life, and as important as this is the importance of every event associated with it and every institution, organization or company it works in, especially in this era in which All sectors and humanitarian activities are witnessing an amazing development around the clock.
Dr. Khaled Abdel Ghaffar during the conference
He added during the second drug conference, that there is no doubt that the pharmaceutical industry, with its permanent developments, is one of the rapidly developing industries that are constantly changing, whether with regard to the theoretical assets of the drug industry or what is related to the applications and technologies related to it, and here comes the role of academic institutions that can with what they own From human and material expertise and capabilities to make a great contribution to the development of the pharmaceutical industry, Egyptian universities and research centers can play a fundamental and pivotal role in achieving the national goal of the pharmaceutical raw materials production project, which is self-sufficiency by making copies of the active pharmaceutical ingredients for the necessary medicines.
The Minister of Higher Education and Scientific Research pointed out that there is another advantage of the partnership between universities and research centers on the one hand and Egyptian pharmaceutical companies on the other hand, which is creating opportunities to innovate pharmaceutical chemicals and new medicines, and Egyptian universities and research centers can play this pioneering role due to their human and mental capabilities. In addition to the fact that many universities and research centers have partnerships with universities abroad that can support this type of project technically and technically, it is necessary to take advantage of the manpower enjoyed by the Egyptian society to enrich this type of scientific research related to drug raw materials. He explained that, for example, AstraZeneca partnered with Oxford University and produced the Corona vaccine together as a result of this cooperation.
He stressed that pharmacy education at the undergraduate level is characterized by diversity, and the courses at this stage provide an appropriate amount of knowledge and skills necessary to graduate a pharmacist who can compete and perform his job role efficiently within the framework of the available fields of work in the field of medicine in the local market. More specialization in academic courses and scientific research topics. Research topics may revolve around the discovery and development of new treatments for diseases, a better understanding of the mechanism of drug action in the body, or the development of new methods for the synthesis of medicinal compounds. Research results remain confined to their laboratories, although universities.
Abdel Ghaffar added that the large resources that the state has pumped into the medical city and the start of manufacturing pharmaceutical raw materials for chronic and common diseases in Egypt and the region and supporting the partnership between academic institutions and pharmaceutical companies in the field of research and development of medicines, will contribute to advancing the development wheel in the pharmaceutical industry.
He pointed out that he could not neglect two essential points that we need to reconsider: the intermediate industries needed for the pharmaceutical industry, such as the manufacture of paper and aluminum foil, and the manufacture of ineffective chemicals included in the composition of the drug, as well as the pricing policy of old medicines, which is less than 10 pounds.
Dr. Khaled Abdel Ghaffar, Minister of Higher Education and Scientific Research, revealed that the pharmaceutical industry occupies a great importance that stems from its close relationship to human health and life, and as important as this is the importance of every event associated with it and every institution, organization or company it works in, especially in this era in which All sectors and humanitarian activities are witnessing an amazing development around the clock.
Dr. Khaled Abdel Ghaffar during the conference
He added during the second drug conference, that there is no doubt that the pharmaceutical industry, with its permanent developments, is one of the rapidly developing industries that are constantly changing, whether with regard to the theoretical assets of the drug industry or what is related to the applications and technologies related to it, and here comes the role of academic institutions that can with what they own From human and material expertise and capabilities to make a great contribution to the development of the pharmaceutical industry, Egyptian universities and research centers can play a fundamental and pivotal role in achieving the national goal of the pharmaceutical raw materials production project, which is self-sufficiency by making copies of the active pharmaceutical ingredients for the necessary medicines.
The Minister of Higher Education and Scientific Research pointed out that there is another advantage of the partnership between universities and research centers on the one hand and Egyptian pharmaceutical companies on the other hand, which is creating opportunities to innovate pharmaceutical chemicals and new medicines, and Egyptian universities and research centers can play this pioneering role due to their human and mental capabilities. In addition to the fact that many universities and research centers have partnerships with universities abroad that can support this type of project technically and technically, it is necessary to take advantage of the manpower enjoyed by the Egyptian society to enrich this type of scientific research related to drug raw materials. He explained that, for example, AstraZeneca partnered with Oxford University and produced the Corona vaccine together as a result of this cooperation.
He stressed that pharmacy education at the undergraduate level is characterized by diversity, and the courses at this stage provide an appropriate amount of knowledge and skills necessary to graduate a pharmacist who can compete and perform his job role efficiently within the framework of the available fields of work in the field of medicine in the local market. More specialization in academic courses and scientific research topics. Research topics may revolve around the discovery and development of new treatments for diseases, a better understanding of the mechanism of drug action in the body, or the development of new methods for the synthesis of medicinal compounds. Research results remain confined to their laboratories, although universities.
Abdel Ghaffar added that the large resources that the state has pumped into the medical city and the start of manufacturing pharmaceutical raw materials for chronic and common diseases in Egypt and the region and supporting the partnership between academic institutions and pharmaceutical companies in the field of research and development of medicines, will contribute to advancing the development wheel in the pharmaceutical industry.
He pointed out that he could not neglect two essential points that we need to reconsider: the intermediate industries needed for the pharmaceutical industry, such as the manufacture of paper and aluminum foil, and the manufacture of ineffective chemicals included in the composition of the drug, as well as the pricing policy of old medicines, which is less than 10 pounds.